产品详情
Targets
Target | Value | |
---|---|---|
EphB4 | ED50 | 25nM |
C-Raf | IC50: 0.395μM | |
c-Src | IC50: 1.266μM | |
c-Abl | IC50: 1.667μM | |
Tie-2 | IC50: >10μM | |
Axl | IC50: >10μM | |
HER1 | IC50: >10μM | |
PKA | IC50: >10μM | |
CDK1 | IC50: >10μM | |
PKB | IC50: >10μM | |
PDK-1 | IC50: >10μM | |
FGFR3 | IC50: >10μM | |
c-Met | IC50: >10μM |
In vitro (25°C) | DMSO | 90 mg/mL (178.75 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (5.95 mM) | ||
In vivo | NMP+PEG300 (10+90, v+v) | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.86 mL | 99.3 mL | 198.61 mL |
0.5 mM | 3.97 mL | 19.86 mL | 39.72 mL |
1 mM | 1.99 mL | 9.93 mL | 19.86 mL |
5 mM | 0.4 mL | 1.99 mL | 3.97 mL |
*The above data is based on the productmolecular weight 503.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10661 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 503.5 |
Formula | C26H20F3N7O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 940310-85-0 |
Synonyms | NVPBHG712 |
SMILES | CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=NC(=NC4=C3C=NN4C)C5=CN=CC=C5 |
产品标签
Product Questions
Product Questions
LGX 818 (Encorafenib)
LGX 818 (Encorafenib)是一种Raf激酶抑制剂,具有潜在的抗肿瘤活性。
B-Raf-inhibitor 1
B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。
PF-04880594
PF-04880594是RAF抑制剂,BRAF/BRAFV599E和c-RAF的IC50值分别为0.19 nM/0.13 nM和0.39 nM。
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
RO5126766 (CH5126766)
RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶(MAPK)具有特异性的蛋白激酶抑制剂,具有潜在的抗肿…